Sarepta Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Sarepta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $6.7M | 53k | 124.89 |
| 2024-06-30 | $8.5M | 54k | 158.00 |
| 2023-12-31 | $523k | 5.4k | 96.43 |
| 2023-09-30 | $666k | 5.5k | 121.22 |
| 2023-06-30 | $629k | 5.5k | 114.52 |
| 2023-03-31 | $703k | 5.1k | 137.83 |
| 2022-12-31 | $659k | 5.1k | 129.58 |
| 2022-09-30 | $577k | 5.2k | 110.54 |
| 2022-06-30 | $391k | 5.2k | 74.96 |
| 2022-03-31 | $421k | 5.4k | 78.12 |
| 2019-03-31 | $11k | 91 | 120.88 |
| 2018-12-31 | $10k | 91 | 109.89 |
| 2018-09-30 | $14k | 87 | 160.92 |
| 2018-03-31 | $2.0M | 28k | 74.08 |
| 2017-12-31 | $1.5M | 28k | 55.63 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors